schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."..

here are 4 mass. biotechs making noise at the ash conference so far.

'i mean all she pretty much did was spread the word and reach out to her baby daddies, so she felt like, "that's how i helped, " continued the insider, referring to ex. november 2013  (16).previous efforts to treat babies with the same protein shortly after birth had failed, schneider said... he wasn't certain, though, how much he'd be able to work before then.